Biomarker for diagnosis and prognosis of Multiple Sclerosis (MS)

Patent number:

EP24382907

No items found.

Countries:

Spain

Regions:

Community of Madrid

Centers:

CSIC, UNIVERSIDAD AUTONOMA DE MADRID, CIBERNED CENTRO DE INVESTIG BIOMEDICA EN RED ENFERMEDADES NEURODEGENERATIVAS

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

- Novel biomarker for diagnosis and prognosis - Minimally invasive method through blood or CFS extraction - Known molecular mechanism of action - Novel pre-clinical model for MS

Comments

Other related patents

Health

Identification of therapeutic candidates for Congenital Central hypoventilation Syndrome (CCHS)

Countries

Spain

Health

Textile

PROCEDURE FOR OBTAINING A TEXTILE MATERIAL CARRYING MOLECULES OF PHARMACOLOGICAL INTEREST AND MATERIAL THUS OBTAINED

Countries

Spain

Health

METHOD FOR PREDICTING THE BENEFIT OF ENDOCRINE THERAPY IN BREAST CANCER

Countries

Spain

Get back to patents directory